Anti-Inflammatory Activity of Tetracyclines

Dermatologic Clinics

Volumn 25, Issue 2, 2007, Pages 133-135

  Webster, Guy ^a   Del Rosso, James Q ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b VALLEY HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MINOCYCLINE; PROTEINASE; TETRACYCLINE;

ACNE VULGARIS; ANTIINFLAMMATORY ACTIVITY; BULLOUS SKIN DISEASE; CELL MIGRATION; CHEMOTAXIS; DRUG INHIBITION; DRUG MECHANISM; ENZYME INHIBITION; GRANULOMATOSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REVIEW; ROSACEA; SKIN INFLAMMATION;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; HUMANS; SKIN DISEASES; TETRACYCLINES;

EID: 34147148650     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.01.012     Document Type: Review

References (24)

1. Webster G.F., McGinley K.J., and Leyden J.J. Inhibition of lipase production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracyclines and erythromycin. Br J Dermatol 104 (1981) 453-457
2. Webster G.F., Leyden J.J., McGinley K.J., et al. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by sub-minimal inhibitory concentrations of tetracyclines and erythromycin. Antimicrob Agents Chemother 21 (1982) 770-772
3. Esterly N.B., Furey N.L., and Flannagan L.E. The effect of antimicrobial agents on chemotaxis. J Invest Dermatol 70 (1978) 51-55
4. Esterly N.B., Kovansky J.S., Furey N.S., et al. Neutrophil chemotaxis in patients with acne receiving tetracycline. Arch Dermatol 120 (1984) 1308-1313
5. Gabler W.L., and Creamer H.R. Suppression of human neutrophil functions by tetracycline. J Periodontal Res 26 (1991) 52-58
6. Goodheart G.L. Further evidence of therole of bivalent cations in leukocyte chemotaxis. J Reticuloendothel Soc 25 (1979) 545-554
7. Webster G.F., Toso S.M., and Hegemann L.R. Inhibition of in vitro granuloma formation by tetracyclines and ciprofloxacin: involvement of protein kinase C. Arch Dermatol 130 (1994) 748-752
8. Maata M., Kari O., Tervahartiala T., et al. Tera fluid levels of MMP-8 are elevated in ocular rosacea-treatment effect of oral doxycycline. Graefes Arch Clin Exp Ophthalmol 244 (2006) 957-962
9. Kim H.S., Luo L., Pflugfelder S.C., et al. Doxycycline inhibits TGF-beta-1 induced MMP-9 via Smad and MAPK pathways in cultured human corneal epithelial cells. Invest Ophthalmol Vis Sci 46 (2005) 840-848
10. Golub L.M., Ramamurthy N.S., Mcnamara T.F., et al. Tetracyclines inhibit tissue collagenase activity a new mechanism in the treatment of periodontal disease. J Periodontal Res 19 (1984) 651-655
11. Ciancio S., and Ashley R. Safety and efficacy of sub-antimicrobial doxycycline therapy in patients with adult periodontitis. Adv Dent Res 12 (1998) 27-37
12. Lee C.Z., Xu H.B., Hashimoto T., et al. Doxycycline suppresses cerebral MMP-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke 35 (2004) 1715-1719
13. Saikali Z., and Singh G. Doxycycline and other tetracyclines in the treatment of bone metastasis. Anticancer Drugs 14 (2004) 773-778
14. Dezube B.J., Krown S.E., Lee J.Y., et al. Randomized phase II trial of matrix metalloproteinase inhibitor col-3 in AIDS-related Kaposi's sarcoma. J Clin Oncol 24 (2006) 1389-1394
15. Onoda T., Ono T., Dhar D.K., et al. Tetracycline analogs (doxycycline and col-3) induce caspase dependant and independent apoptosis in human cancer cells. Int J Cancer 118 (2006) 1309-1315
16. Sanchez-Mejia R.O., Ona V.O., and Friedlander R.M. Minocycline reduces traumatic brain injury-mediated caspase 1 activation tissue damage, and neurological dysfunction. Neurosurgery 28 (2001) 1393-1401
17. Chen M., Ona V.O., Mingwei L., et al. Minocycline inhibits caspase 1 and caspase 3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6 (2000) 797-801
18. Skidmore R., Kovach R., Walker C., et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 139 (2003) 459-464
19. Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol, in press.
20. Sapadin A.N., and Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54 (2006) 258-265
21. Bachelez H., Senet P., Cadranel J., et al. The use of tetracyclines for treatment of sarcoidosis. Arch Dermatol 137 (2001) 69-73
22. Ohtsuka S., Yanadori A., Tabata H., et al. Sarcoidosis with giant parotomegaly. Cutis 68 (2001) 199-200
23. Senet P., Bachelez H., Olivaud L., et al. Minocycline for the treatment of cutaneous silica granulomas. Br J Dermatol 140 (1999) 985-987
24. Veller-Formosa C., Catalano P., and Peserico A. Minocycline in granulomatous cheilitis: experience with six cases. Dermatology 185 (1992) 220-222